TABLE 1.
Inhibition of C. parvum forms in cell culture by prophylactic and therapeutic treatments with Bobel-24
Treatment | Concn | Parasite counta | Growth inhibition
|
|
---|---|---|---|---|
% | Score | |||
Bobel-24 | ||||
Prophylactic treatment against sporozoitesb | 90 μM | 14.11 ± 2.28 | 27.8 | 0 |
Prophylactic treatment against cellsc | 90 μM | 12.50 ± 2.18 | 36 | 1 |
Therapeutic treatment against DEd | 90 μM | 0.43 ± 0.02 | 99.6 | 4 |
PRM | 2 mg/ml | 0.89 ± 0.02 | 95.4 | 4 |
Mucin | 0.2 mg/ml | 7.75 ± 0.39 | 60.4 | 2 |
Medium + DMSO | 0.02% | 15.31 ± 2.11 | 21.7 | 0 |
Medium | 19.56 ± 1.78 | 0 | 0 |
Shown is the mean number of DE per field ± the standard deviation. Values were determined by counting meronts and gamonts (<3 μm) to avoid counting nonviable but adherent sporozoites and merozoites.
Sporozoite suspension incubated with Bobel-24 at 37°C for 30 min before use.
HCT-8 cells incubated with Bobel-24 at 37°C for 30 min before infection.
Treatment of infected HCT-8 cells with Bobel-24 at 37°C for 24 h in 5% CO2.